- Quest Diagnostics (DGX) Q3 results: Revenues: $1,956M (+3.5%).
- Net Income: $215M (+0.9%); EPS: $1.56 (+2.0%); non-GAAP Net Income: $241M (+2.6%); non-GAAP EPS: $1.76 (+4.8%).
- CF Ops: $895M (-1.1%).
- 2019 guidance: Revenues: ~$7.72B from $7.60B - 7.75B; EPS: $5.48 - 5.53 from >$5.29; non-GAAP EPS: $6.45 - 6.50 from >$6.40; cash flow ops: ~$1.3B (unch).
- Previously: Quest Diagnostics EPS beats by $0.05, beats on revenue (Oct. 22)
Quest Diagnostics beats Q3 consensus
Recommended For You
About DGX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| DGX | - | - |
| Quest Diagnostics Incorporated | ||